Back to ABBV
FAYEZ SAROFIM & CO ABBV Position History
AbbVie Inc. • Healthcare
Quarters held
16
Latest value
$37.6M
Q3 2026
Peak value
$488.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $404.5M |
| Q4 2025 | $124.7M |
| Q4 2025 | $41M |
| Q4 2025 | $20.2M |
| Q1 2026 | $397.3M |
| Q1 2026 | $133.6M |
| Q1 2026 | $38.9M |
| Q1 2026 | $29.6M |
| Q2 2026 | $464.6M |
| Q2 2026 | $169.1M |
| Q2 2026 | $55.2M |
| Q2 2026 | $35M |
| Q3 2026 | $488.7M |
| Q3 2026 | $138.9M |
| Q3 2026 | $57.3M |
| Q3 2026 | $37.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $37.6M | 143.7K | — | — |
| Q3 2026 | $57.3M | 218.9K | — | — |
| Q3 2026 | $138.9M | 531.1K | — | — |
| Q3 2026 | $488.7M | 1.87M | — | — |
| Q2 2026 | $35M | 139.2K | — | — |
| Q2 2026 | $55.2M | 219.2K | — | — |
| Q2 2026 | $169.1M | 672.2K | — | — |
| Q2 2026 | $464.6M | 1.85M | — | — |
| Q1 2026 | $29.6M | 136.2K | — | — |
| Q1 2026 | $38.9M | 178.8K | — | — |
| Q1 2026 | $133.6M | 614.5K | — | — |
| Q1 2026 | $397.3M | 1.83M | — | — |
| Q4 2025 | $20.2M | 88.4K | — | — |
| Q4 2025 | $41M | 179.6K | — | — |
| Q4 2025 | $124.7M | 545.7K | — | — |
| Q4 2025 | $404.5M | 1.77M | — | — |